Skip to Main Content


Taking stock of the drug industry from the lab to the medicine chest. We follow clinical trials, dig deep into FDA drug approvals, track Big Pharma lobbyists and break down financials. From supply chains to Medicare negotiations, count on STAT.

Sign up for our free Pharmalot newsletter and subscribe to STAT+ for exclusive coverage and analysis of the pharma industry — from drug pipelines to boardroom shakeups.

All Coverage